Company profile
DENTSPLY SIRONA INC.
NASDAQ:XRAYMedical/Dental Instruments
Drug pipeline (8)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| CITANEST FORTE DENTAL | approved | — | 0 | — |
| CITANEST PLAIN DENTAL | approved | — | 0 | — |
| DURANEST | approved | — | 0 | — |
| ORAQIX | approved | — | 1 | approved |
| POLOCAINE | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01591616 | phase4 | completed | 2010-04-01 | 2012-04-01 | Dentsply International | Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel |
FDA applications (8)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 021451 | 2003-12-19 | NDA | DENTSPLY PHARMACEUTICAL INC | |||||
Loading… | ||||||||
| ANDA 089517 | 1988-04-14 | ANDA | DENTSPLY PHARMACEUTICAL | |||||
Loading… | ||||||||
| ANDA 088653 | 1984-08-21 | ANDA | DENTSPLY PHARMACEUTICAL | |||||
Loading… | ||||||||
| NDA 021380 | — | NDA | DENTSPLY PHARMACEUTICAL INC | |||||
Loading… | ||||||||
| NDA 021381 | — | NDA | DENTSPLY PHARMACEUTICAL INC | |||||
Loading… | ||||||||